Vietnam: VinaCapital pares stake in FPT; Taisho ups holding in DHG Pharma

VinaCapital has offloaded nearly 3.9 million shares in technology giant FPT Corporation to Australia’s Macquarie Bank and Florida Retirement while Japan’s Taisho has hiked its interest in Vietnam-listed DHG Pharma to nearly 35 per cent.

VinaCapital sells nearly 4m shares of FPT Corp

Ho Chi Minh-based asset management VinaCapital has offloaded nearly 3.9 million shares of technology giant FPT Corporation to Australia’s Macquarie Bank and Florida Retirement for estimation of VND170 billion ($7.34 million).

According to Vietnam Securities Depository, VOF Investment Limited has transferred 3.05 million shares to Macquarie Bank and 500,000 shares to Florida Retirement.

The transaction value was not disclosed. However, based on the current price of FPT shares in the stock market at VND 44,200 per share, the value of the transaction is estimated at VND170 billion.

Macquarie Bank had earlier purchased over 1.572 million shares, equivalent to 5.74 per cent of entertainment group Yeah1’s charter capital, becoming a major shareholder in the Vietnamese entertainment group.

Japan’s Taisho ups stake in Vietnam-listed DHG Pharma to nearly 35%

Japan’s Taisho Pharmaceutical Holdings has proposed to purchase an additional nearly 1 million shares in Vietnam-listed DHG Pharma JSC, lifting its ownership to nearly 35 per cent, according to a disclosure by the Ho Chi Minh City Stock Exchange.

The Japanese pharma company has planned to make a public offer of 925,200 shares with voting rights, which is equivalent to 0.7 per cent of the DHG Pharrma. At the proposed offer price of VND93,000 apiece, Taisho was said to spend about VND86 billion ($3.7 million) to buy the shares.

Taisho is currently a major shareholder of DHG with over 44,83 million shares, equivalent to 34.29 per cent of the company’s charter capital. After the sale, the number of shares will increase to over 45.76 million, equivalent to 34.99 per cent of the charter capital.

Taisho is still cementing its position as DHG Pharma’s second largest investor after the State Capital Investment Corporation (SCIC).

Also Read:

VinaCapital, South Korea’s Kiwoom partner for Vietnam investments

VinaCapital Ventures bets on logistics, fintech and digital media

Japan’s Taisho close to acquiring Bristol-Myers OTC unit in $1.6b deal